TLE3

Information TLE3

Description

This gene encodes a transcriptional co-repressor protein that belongs to the transducin-like enhancer family of proteins. The members of this family function in the Notch signaling pathway that regulates determination of cell fate during development. Expression of this gene has been associated with a favorable outcome to chemotherapy with taxanes for ovarian carcinoma. Alternate splicing results in multiple transcript variants. Additional alternatively spliced transcript variants of this gene have been described, but their full-length nature is not known. [provided by RefSeq, Sep 2013]

Full Name

TLE family member 3, transcriptional corepressor

Source NCBI

ReMap Statistics

Datasets
3
Biotypes
2
Peaks
139,710
Non-redundant peaks
89,483

TF Classification

Super Class
Unknown
Class
Unknown
Familly
Unknown
Sub Familly
Unknown

Source TFClass

External IDs

JASPAR
Ensembl
ENSG00000140332
UniProt
Q04726
Genevisible
Q04726
RefSeq
NM_001105192
Aliases
ESG; ESG3; GRG3; HsT18976; KIAA1547
All peaks TLE3
Download BED file
Non redundant peaks TLE3
Download BED file
SEQUENCES TLE3
Download FASTA file
DOWNLOAD All ReMap
Got to catalogue

Datasets Table for TLE3

Target name Target modification Ecotype/Strain Biotype Biotype modification Source Species Experiment Peaks
TLE3 MCF-7 GEO Homo sapiens GSE41561 7,873
TLE3 LNCaP GEO Homo sapiens GSE94682 70,331
TLE3 LNCaP r1881 GEO Homo sapiens GSE94682 61,506
Target name Target modification Ecotype/Strain Biotype Biotype modification Source Species Experiment Peaks

ReMap is a database of transcriptional regulators peaks derived from curated ChIP-seq, ChIP-exo, DAP-seq experiments in Human and Thaliana.

You are using the 2020 ReMap (3rd) release.
The ReMap catalogues (2020, 2018, 2015) are under CC BY-NC 4.0 international license, while ReMapEnrich, remap-pipeline under GNU GPLv3 licence.

Inserm TAGC
AMU AMU-MESO

This work was granted access to the HPC resources of Aix-Marseille Université financed by the project Equip@Meso (ANR-10-EQPX-29-01) of the program "Investissements d’Avenir" supervised by the Agence Nationale de la Recherche.